Keywords: Onyx, Proteolix, Carfilizomib, Bayer, Nexavar, M&A, Takeda, Celgene, Mutliple myeloma

Onyx to buy Proteolix for as much as $850 million to get blood cancer drug

Article | 12 October 2009

Print This

California, USA-based Proteolix has agreed to a takeover bid from Onyx Pharmaceuticals, valuing the firm at a potential $851 million based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in